Gold tier: mechanically validated evidence, with its primary source.
709 evidence items · page 24 / 29
7.3 per_100_person-yearsHBsAg seroconversion incidence among regular blood donors in Abidjan decreased from 7.3 per 100 person-years in 1992–1994 to 0.2 per 100 person-years in 2010–2012.
Côte d'Ivoirehépatite Bobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
75 /mm³Among hospitalized HIV-positive adults in West Africa, the median CD4 count was 75/mm³.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
17.7 %The median rate of loss to follow-up was 17.7%.
Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations
20 %Mortality in adults admitted to hospital living with HIV was 20%.
Côte d'IvoireVIH/sidapublished 2015The lancet. HIVeurope_pmcdocument of 8 observations
37 %Of the 19 isolated TB strains from inmates at the Correctional and Detention Facility of Abidjan, 7 (37%) had multi-drug resistant TB.
Côte d'Ivoiremulti-drug resistant TBobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations
65 %Syndrome of pure meningeal irritation was present in 65% of patients with cryptococcal meningitis.
Côte d'Ivoireméningite cryptococciqueobserved 2008 to 2011published 2017Journal de mycologie medicaleeurope_pmcdocument of 11 observations
The highest malaria cases’ prevalence was observed in children under 5 years of age.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
1.2 %At month 6, 1.2% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz were dead.
Côte d'IvoireVIH/sidaobserved month 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50
1 patientDuring 34 months of follow-up, one patient (1.6%) had third-line treatment.
Côte d'IvoireVIH/sidaobserved 34 monthspublished 2010Le Mali medicaleurope_pmcdocument of 17 observations
0.9 sensitivityqHBsAg levels ≤ 10 IU/mL at month 12 had sensitivity of 0.90 and specificity of 1.00 for predicting HBsAg seroclearance.
Côte d'Ivoirehépatite Bobserved month 12published 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156
465 /mm3The median pre-antiretroviral treatment CD4 count was 465 cells per cubic millimeter among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.
Côte d'IvoireVIH/sidapublished 2022BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/s12879-022-07082-2
0.6 %At 10 years, scale-back strategies increase projected HIV deaths by 0.6% to 39.1%.
Côte d'IvoireVIH/sidaobserved 10 yearspublished 2017Annals of internal medicineeurope_pmcdocument of 6 observations
2.8 %Arterial thrombosis was found in 1 out of 36 HIV-infected patients, representing 2.8%.
Côte d'Ivoirearterial thrombosis · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations
60 patientsOnly 60 AEB patients completed one actual month of antiretroviral treatment.
Côte d'IvoireVIH/sidaobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations
6.8 per_100_person-yearsIn a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of lipodystrophy was 6.8 per 100 person-years of follow-up after 3 years of combined antiretroviral therapy.
Côte d'Ivoirelipodystrophy · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations
38 %Among 823 hospitalized HIV-positive adults in West Africa, 38% died during hospitalization.
Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
26.5 hoursThe average delay of consultation after AEB was 26.5 hours, ranging from 1 to 240 hours.
Côte d'Ivoireaccidental exposure to bloodobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations
4.3 aORHIV infection was associated with cervical cancer (aOR 4.3 [CI 2.2-8.3]).
Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations
5.8 yearsParticipants in the Temprano ANRS 12136 posttrial phase had a median follow-up duration of 5.8 years.
Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations
40 %A Bti-based larviciding intervention reduced malaria case prevalence by 40% in community cross-sectional surveys.
Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations
7.9 odds_ratioCervical cancer was associated with HIV infection with an odds ratio of 7.9.
Côte d'Ivoirecancer du col de l'utérus · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108
73,525 individualsThe study included 73,525 ART-naïve PLHIV-1 adults aged >16 years initiating ART.
Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations
0.5 per_100_person_weeksMalaria incidence rates remained below 0.5 cases per 100 person-weeks in the >18-year-old age group.
Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations
6 %Thirteen (6%) of patients in the efavirenz group experienced AIDS-defining illnesses.
Côte d'IvoireAIDS-defining illnessespublished 2021The Lancet. Infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.1016/s1473-3099(20)30869-0
70.2 %Most of the treatment-naïve patients (70.2%) had CD4-T cell count ≥500 cells/mm3.
Côte d'IvoireVIH/sidaobserved 2012published 2015PloS oneeurope_pmcdocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.